
April 04, 2024
Avenira Limited (ASX: AEV) (“Avenira” or “the Company”) is pleased to provide the following update in relation to the Company’s operations and finances.
Capital Raising
Avenira has completed the capital raising announced on 18 March 2024 to raise gross proceeds of $1.251 million and net proceeds to AEV of $1.193 million (Capital Raising).
Advanced Lithium Electrochemistry Ltd (“Aleees”)
The Company provides the following update with respect to the Licence and Technology Transfer Agreement entered into between Avenira and Aleees on 26 September 2023 (Licence Agreement).
Aleees and Avenira have agreed to the deferral of the two remaining USD$750,000 tranches owing under the Licence Agreement until 1 January 2025 and 1 April 2025.
Avenira and Aleees have made no changes to the Licence Agreement other than the deferral of the tranche payment dates referred to above, and there are no new or additional obligations on Avenira as a result of the payment deferrals agreed with Aleees.
The deferral of the Aleees payments has no impact on any current work being undertaken in relation to the Licence Agreement and will not impact any future work programs between Avenira and Aleees.
Reinstatement to Quotation
Avenira confirms that it is in compliance with the ASX Listing Rules and is not aware of any reason for its securities not to be reinstated to quotation.
Avenira confirms that, following the completion of the Capital Raising, it has sufficient working capital to carry out its business objectives referred to below.
In the opinion of the directors there are reasonable grounds to believe that Avenira will be able to pay its debts as and when they become due and payable.
Click here for the full ASX Release
This article includes content from Avenira Limited, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.
AEV:AU
The Conversation (0)
17 June
Wonarah Mine Management Plan Approved by the NT Government
Avenira Limited (AEV:AU) has announced Wonarah Mine Management Plan Approved by the NT GovernmentDownload the PDF here. Keep Reading...
30 April
Quarterly Activities/Appendix 5B Cash Flow Report
Avenira Limited (AEV:AU) has announced Quarterly Activities/Appendix 5B Cash Flow ReportDownload the PDF here. Keep Reading...
09 March
Investment from Sichuan Hebang Biotechnology
Avenira Limited (AEV:AU) has announced Investment from Sichuan Hebang BiotechnologyDownload the PDF here. Keep Reading...
11 February
Termination of Aleees License and Technology Agreement
Avenira Limited (AEV:AU) has announced Termination of Aleees License and Technology AgreementDownload the PDF here. Keep Reading...
10h
Laguna Verde Resource Increase Based on Recent Licence Acquisition
CleanTech Lithium PLC ("CleanTech Lithium" or "CleanTech" or the "Company") (AIM: CTL, Frankfurt:T2N), an exploration and development company advancing sustainable lithium projects in Chile, announces an updated resource estimate for its Laguna Verde project following the recent acquisition of... Keep Reading...
05 November
Top 5 Canadian Lithium Stocks of 2025
The global lithium market saw sharp swings in Q3 2025 as shifting supply dynamics, policy uncertainty, and geopolitical developments reshaped investor sentiment. After hitting a four-year low in June, benchmark lithium carbonate prices briefly surged to an 11 month high in August on speculation... Keep Reading...
24 October
PMET Releases Lithium-Only Feasibility Study for Shaakichiuwaanaan in Québec
PMET Resources (ASX:PMT, TSX:PMET,OTCQX:PMETF) has completed a lithium-only feasibility study on the CV5 deposit of its Shaakichiuwaanaan lithium project in Northern Québec. The company said the feasibility study confirms the project is a large-scale and long-life operation, with CV5’s probable... Keep Reading...
Latest News
Latest Press Releases
Related News
TOP STOCKS
American Battery4.030.24
Aion Therapeutic0.10-0.01
Cybin Corp2.140.00







